- 全部删除
您的购物车当前为空
NLRP3-IN-34(Compound T10)作为一种NLRP3炎性体的抑制剂,能够有效抑制ROS的产生,并阻断依赖NLRP3炎性体的IL-1β生成(J774A.1,IC50为0.48 μM),同时抑制细胞焦亡(pyroptosis).此外,在C57BL/6小鼠模型中,NLRP3-IN-34对于DSS诱导的腹膜炎表现出了抗炎活性.

NLRP3-IN-34(Compound T10)作为一种NLRP3炎性体的抑制剂,能够有效抑制ROS的产生,并阻断依赖NLRP3炎性体的IL-1β生成(J774A.1,IC50为0.48 μM),同时抑制细胞焦亡(pyroptosis).此外,在C57BL/6小鼠模型中,NLRP3-IN-34对于DSS诱导的腹膜炎表现出了抗炎活性.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 10-14周 | |
| 50 mg | 待询 | 10-14周 |
| 产品描述 | NLRP3-IN-34 (Compound T10) acts as an inhibitor of the NLRP3 inflammasome. It blocks the production of reactive oxygen species (ROS) and impedes the formation of NLRP3 inflammasome-dependent IL-1β (J774A.1, IC50 of 0.48 μM), while also inhibiting pyroptosis (cell suicide). Additionally, NLRP3-IN-34 displays anti-inflammatory activity in a C57BL/6 mouse model for DSS-induced peritonitis. |
| 分子量 | 430.45 |
| 分子式 | C26H22O6 |
| CAS No. | 1392502-55-4 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容